AI-Predicted mTOR Inhibitor Reduces Cancer Cell Proliferation and Extends the Lifespan of C. elegans
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms24097850 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Tinka Vidovic und 4 weiteren Autor:innen. Beteiligte Einrichtung: Tinka Therapeutics, Fra Ivana Rozica 7, 21276 Vrgorac, Croatia. Hauptthemen laut MEDLINE: Caenorhabditis elegans Proteins, Neoplasms. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Swiss National Science Foundation.
Abstract (Originalsprache)
The mechanistic target of rapamycin (mTOR) kinase is one of the top drug targets for promoting health and lifespan extension. Besides rapamycin, only a few other mTOR inhibitors have been developed and shown to be capable of slowing aging. We used machine learning to predict novel small molecules targeting mTOR. We selected one small molecule, TKA001, based on in silico predictions of a high on-target probability, low toxicity, favorable physicochemical properties, and preferable ADMET profile. We modeled TKA001 binding in silico by molecular docking and molecular dynamics. TKA001 potently inhibits both TOR complex 1 and 2 signaling in vitro. Furthermore, TKA001 inhibits human cancer cell proliferation in vitro and extends the lifespan of Caenorhabditis elegans, suggesting that TKA001 is able to slow aging in vivo.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Tinka Therapeutics, Fra Ivana Rozica 7, 21276 Vrgorac, Croatia.
- Laboratory of Extracellular Matrix Regeneration, Institute of Translational Medicine, Department of Health Sciences and Technology, ETH Zürich, CH-8603 Schwerzenbach, Switzerland.
- Palladin Institute of Biochemistry of the NAS of Ukraine, 02000 Kyiv, Ukraine.
- Lewis-Sigler Institute for Integrative Genomics, Princeton University, Princeton, NJ 08540, USA.
ORCID-Profile: Tinka Vidovic, Collin Y Ewald
Förderung
- Swiss National Science Foundation
Zitieren
APA
Vidovic, T., Dakhovnik, A., Hrabovskyi, O., MacArthur, M. R., & Ewald, C. Y. (2023). AI-Predicted mTOR Inhibitor Reduces Cancer Cell Proliferation and Extends the Lifespan of C. elegans. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24097850
Vancouver
Vidovic T, Dakhovnik A, Hrabovskyi O, MacArthur MR, Ewald CY. AI-Predicted mTOR Inhibitor Reduces Cancer Cell Proliferation and Extends the Lifespan of C. elegans. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24097850
BibTeX
@article{Vidovic2023,
author = {Vidovic, Tinka and Dakhovnik, Alexander and Hrabovskyi, Oleksii and MacArthur, Michael R and Ewald, Collin Y},
title = {AI-Predicted mTOR Inhibitor Reduces Cancer Cell Proliferation and Extends the Lifespan of C. elegans},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms24097850}
}
EUVIMED